我的GauchTM:一个以患者为中心的数字健康应用程序,用于高氏病
Majdolen Istaiti1, Elena Shulman1, Tama Dinur1
1Gaucher Unit, The Eisenberg R&D Authority, Shaare Zedek Medical Center, Jerusalem, Israel.
mHealth
|November 10, 2025
概括
一个Gaucher病 (GD) 应用程序在患者满意度方面显示了适度的改善,但面临着低参与度. 未来用于罕见疾病的数字健康工具需要增强功能和患者教育,以获得更好的结果.
科学领域:
- 生物技术是生物技术.
- 数字健康数字健康
- 罕见疾病 罕见疾病
背景情况:
- 氏病 (Gaucher disease,简称GD) 是一种罕见的遗传性疾病,由GBA1基因变异引起,导致酶缺乏和葡萄糖脑蛋白积累.
- 目前的治疗方法,如酶替代疗法 (ERT) 和基质减少疗法 (SRT) 改善了管理,但对于1型GD (GD1) 仍然存在挑战.
- 数字健康技术为GD管理提供了持续监测,遵守跟踪和患者报告的结果的潜力.
研究的目的:
- 评估GD1.0成年人的GD1.0特定移动应用程序MyGauch v1.0的实用性和影响.
- 通过使用MyGauch应用程序来评估患者对医疗管理的满意度.
主要方法:
- MyGauch v1.0应用程序是在INTEGRA平台上开发的,集成了遗传,临床,实验室和生物标记数据.
- 该应用程序包括用于跟踪症状,药物坚持和患者报告结果 (PROM) 的功能,并提供安全的数据传输.
- 90名使用ERT或SRT的GD1成年人被录取;使用特定的PROM测量治疗满意度.
主要成果:
- 在使用MyGauch应用程序时,观察到对GD医疗管理的满意度略有改善.
- 这种改善与人口,疾病或治疗相关因素无关.
- 限制包括高非参与率,有限的功能利用率和缺乏个性化的反.
结论:
- MyGauch v1.0应用程序代表了一种新的方法,但用户参与度较低需要改进功能和患者教育.
- 未来的研究应该专注于克服在罕见疾病管理中采用数字工具的采用障碍.
- 开发针对患者需求的综合性自我管理解决方案对于罕见疾病护理至关重要.
相关概念视频
01:29Chronic Pancreatitis II: Collaborative Care
303
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
303
01:24Parkinson's Disease: Treatment
954
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
954
01:13Patient-centered Care
2.9K
Patient-centered care involves delivering care beyond inpatient hospitalization. Reflective practice can enhance a patient-centered approach. Reflective practice is a process of reasoning that considers all aspects of the present situation, including practicalities, learning from personal practice, and consideration of patient needs. Patients appreciate care decisions made while considering their input. Involving the patient in their care provides the patient with a sense of contribution rather...
2.9K
01:27Peripheral Artery Disease III: Interprofessional Care
231
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
231
01:24Cystic Fibrosis: Management
457
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
457
01:22Alzheimer's Disease: Treatment
782
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
782